Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis HN019 and Reduced Pro-inflammatory Cytokine Levels

Doses used in studies
  • lozenge/day: 2 (median 2, IQR 22) 1 study
  • lozenges/day: 2 (median 2, IQR 22) 1 study
1 of 1 paper
Back to top